Heparin cofactor II: A new marker for pre-eclampsia

Blood Coagulation and Fibrinolysis

Volumn 9, Issue 2, 1998, Pages 205-208

  Bellart, J ^a,d   Gilabert, R ^a   Cabero, L ^b   Fontcuberta, J ^b   Monasterio, J ^c   Miralles, R M ^a  

^a UNIVERSITAT ROVIRA I VIRGILI   (Spain)

^b UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

^c HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

^d HOSPITAL UNIVERSITARI JOAN XXIII   (Spain)

Author keywords

Heparin cofactor II; Hypertension; Pre eclampsia; Pregnancy

Indexed keywords

HEPARIN COFACTOR II;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DELIVERY; DIFFERENTIAL DIAGNOSIS; ESSENTIAL HYPERTENSION; FEMALE; HUMAN; MATERNAL HYPERTENSION; PREECLAMPSIA; PRIORITY JOURNAL; THIRD TRIMESTER PREGNANCY;

EID: 0031966558     PISSN: 09575235     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001721-199803000-00014     Document Type: Article

References (10)

1. Terao T, Maki M, Ikenoue T, Gotoh K, Murata M, Iwasaki H, et al. The relationship between clinical signs and hypercoagulable state in toxemia in pregnancy. Gynecol Obstet Invest 1991; 31: 74-85.
2. Caron C, Goudemand J, Marey A, Beague D, Ducrox G, Drouvin F. Are haemostatic and fibrinolytic parameters predictors of prceclampsia in pregnacy-associated hypertension? Thromb Haemost 1991; 66: 410-414.
3. Bellart J, Gilabert R, Fontcuberta J, Miralles RM, Cabero L. Fibrinolytic changes in normal pregnancy. J Perinat Med 1997; 25: 368-372.
4. Bellart J, Gilabert R, Fontcuberta J, Borrell M, Miralles RM, Cabero L. Levels of coagulation inhibitors and thrombin-antithrombin III complexes in normal pregnancy. Med Sci Res 1997; 25: 699-702.
5. Liu L, Dewar L, Song Y, Kulczycky M, Blajchman MA, Fenton JW, et al. Inhibition of thrombin by antithrombin III and heparin cofactor II in vivo. Thromb Haemost 1998; 73: 405-412.
6. Andrew M, Mitchell L, Barry L, Paes B, Delorme M, Ofosu F, et al. An anticoagulant dermatan sulfate proteoglycan circulates in the pregnant woman and her fetus. J Clin Invest 1992; 89: 321-326.
7. Massouch M, Jatoi A, Gordon FM, Ratnoff OD. Heparin cofactor II activity in plasma during pregnancy and oral contraceptive use. J Lab Clin Med 1989; 114: 679-699.
8. Tollefsen DM, Pestka CA, Monfao WJ. Activation of heparin cofactor II by dermatan sulfate. J Biol Chem 1983; 258: 6713-6716.
9. Bellart J, Gilabert R, Fontcuberta J, Miralles RM, Cabero L. Coagulation and fibrinolytic parameters in normal pregnancy and in pregnancy complicated by intrautcrine growth retardation. Am J Perinat 1998; 15: 81-85.
10. Bellart J, Gilabert R, Fontcuberta J, Borrell M, Miralles RM, Cabero L. Coagulation and fibrinolysis parameters in normal and in hypertensive pregnancies. Hypert Preg 1997 (in press).